Canbreal Therodiagnostics International Inc.
This article was originally published in Start Up
Executive Summary
Canbreal Therodiagnostics is developing diagnostic kits that may help women gauge their risk of developing breast cancer. Analysis of two estrogen dependent cellular markers associated with increased cell division and a cancer's ability to metastasize may provide some quantitative measure of breast cancer risk